The 23rd CIMT Annual Meeting is Europe’s leading conference on cancer immunotherapy research and development, bringing together academic and industry leaders to drive innovation and collaboration. This dynamic program features 8 high-impact plenary sessions, alongside short talks and fast-paced flash talk sessions showcasing cutting-edge research. Engage directly with experts during the Meet the Editor and dedicated EU sessions and explore breakthrough ideas in the poster session and industry exhibition. Covering key topics from cellular therapies, novel targets and emerging tools to clinical translation, the conference offers unparalleled opportunities to connect, learn, and lead the future of cancer treatment. Be part of the community driving the future of cancer immunotherapy.